SomaLogic, Inc.
SLGC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $98 | $82 | $56 | $32 |
| % Growth | 19.7% | 46.1% | 73.6% | – |
| Cost of Goods Sold | $43 | $33 | $23 | $50 |
| Gross Profit | $54 | $48 | $33 | -$18 |
| % Margin | 55.6% | 59% | 59.5% | -54.5% |
| R&D Expenses | $73 | $43 | $31 | $33 |
| G&A Expenses | $153 | $77 | $37 | $33 |
| SG&A Expenses | $157 | $78 | $37 | $33 |
| Sales & Mktg Exp. | $4 | $1 | $0 | $0 |
| Other Operating Expenses | $2 | $1 | $0 | $0 |
| Operating Expenses | $230 | $121 | $68 | $34 |
| Operating Income | -$176 | -$73 | -$34 | -$51 |
| % Margin | -180% | -89.8% | -61.5% | -158.3% |
| Other Income/Exp. Net | $66 | -$14 | -$19 | -$6 |
| Pre-Tax Income | -$110 | -$88 | -$53 | -$57 |
| Tax Expense | -$1 | -$1 | $18 | $0 |
| Net Income | -$109 | -$86 | -$71 | -$57 |
| % Margin | -111.8% | -105.7% | -127.7% | -177.1% |
| EPS | -0.59 | -0.63 | -0.39 | -0.31 |
| % Growth | 6.3% | -61.5% | -25.8% | – |
| EPS Diluted | -0.59 | -0.63 | -0.39 | -0.31 |
| Weighted Avg Shares Out | 184 | 137 | 181 | 181 |
| Weighted Avg Shares Out Dil | 184 | 137 | 181 | 181 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $0 | $0 | $5 |
| Interest Expense | $0 | $1 | $18 | $0 |
| Depreciation & Amortization | $8 | $0 | $3 | $3 |
| EBITDA | -$176 | -$86 | -$32 | -$48 |
| % Margin | -180% | -105.4% | -56.4% | -148.5% |